Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 11, 2004, Pages 3921-3926

  Reddy, Pavan ^a   Maeda, Yoshinobu ^a   Hotary, Kevin ^a   Liu, Chen ^b   Reznikov, Leonid L ^c   Dinarello, Charles A ^c   Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; VORINOSTAT;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL TRACT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOPATHOLOGY; LYMPHOCYTE PROLIFERATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

ANIMALS; BONE MARROW TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; IMMUNE SYSTEM; LEUKEMIA; MICE; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 1642415712     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0400380101     Document Type: Article

References (30)

1. Appelbaum, F. R. (2001) Nature 411, 385-389.
2. Antin, J. H. & Ferrara, J. L. M. (1992) Blood 80, 2964-2968.
3. Teshima, T., Ordemann, R., Reddy, P., Gagin, S., Liu, C., Cooke, K. R. & Ferrara, J. L. (2002) Nat. Med. 8, 575-581.
4. Reddy, P. & Ferrara, J. L. (2003) Blood Rev. 17, 187-194.
5. Riddell, S. R., Murata, M., Bryant, S. & Warren, E. H. (2002) Int. J. Hematol. 76, Suppl. 2, 155-161.
6. Thomas, E., Blume, K. & Forman, S. (1999) Hematopoietic Cell Transplantation (Blackwell Science, Malden, MA).
7. Roth, S. Y., Denu, J. M. & Allis, C. D. (2001) Annu. Rev. Biochem. 70, 81-120.
8. Marks P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T. & Kelly, W. K. (2001) Nat. Rev. Cancer 1, 194-202.
9. Marks, P. A., Miller, T. & Richon, V. M. (2003) Curr. Opin. Pharmacol. 3, 344-351.
10. Leoni, F., Zaliani, A., Bertolini, G., Porro, G., Pagani, P., Pozzi, P., Dona, G., Fossati, G., Sozzani, S., Azam, T., et al. (2002) Proc. Natl. Acad. Sci. USA 99, 2995-3000.
11. Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P. & Gilkeson, G. S. (2003) J. Clin. Invest. 111, 539-552.
12. Hill, G. R., Crawford, J. M., Cooke, K. J., Brinson, Y. S., Pan, L. & Ferrara, J. L. M. (1997) Blood 90, 3204-3213.
13. Teshima, T., Hill, G., Pan, L., Brinson, Y., van den Brink, M. R., Cooke, K. & Ferrara, J. (1999) J. Clin. Invest. 104, 317-325.
14. Yang, Y. G., Sergio, J. J., Pearson, D. A., Szot, G. L., Shimizu, A. & Sykes, M. (1997) Blood 90, 4651-4660.
15. Reddy, P., Teshima, T., Hildebrandt, G., Williams, D. L., Liu, C., Cooke, K. R. & Ferrara, J. L. (2003) Blood 101, 2877-2885.
16. Ichiba, T., Teshima, T., Kuick, R., Misek, D. E., Liu, C., Takada, Y., Maeda, Y., Reddy, P., Williams, D. L., Hanash, S. M. & Ferrara, J. L. (2003) Blood 102, 763-771.
17. Reddy, P., Teshima, T., Kukuruga, M., Ordemann, R., Liu, C., Lowler, K. & Ferrara, J. L. (2001) J. Exp. Med. 194, 1433-1440.
18. Zhang, Y., Louboutin, J. P., Zhu, J., Rivera, A. J. & Emerson, S. G. (2002) J. Clin. Invest. 109, 1335-1344.
19. Hill, G. R. & Ferrara, J. L. (2000) Blood 95, 2754-2759.
20. Murphy, W. J., Kumar, V. & Bennett, M. (1987) J. Exp. Med. 166, 1499-1509.
21. Sykes, M. (2001) Immunity 14, 417-424.
22. Holler, E. (2002) Curr. Opin. Hematol. 9, 479-484.
23. Antin, J. H., Weisdorf, D., Neuberg, D., Nicklow, R., Clouthier, S., Lee, S. J., Alyea, E., McGarigle, C., Blazar, B. R., Sonis, S., et al. (2002) Blood 100, 3479-3482.
24. Saemann, M. D., Bohmig, G. A., Osterreicher, C. H., Burtscher, H., Parolini, O., Diakos, C., Stockl, J., Horl, W. H. & Zlabinger, G. J. (2000) FASEB J. 14, 2380-2382.
25. Skov, S., Rieneck, K., Bovin, L. F., Skak, K., Tomra, S., Michelsen, B. K. & Odum, N. (2003) Blood 101, 1430-1438.
26. Alexander, W. S. (2002) Nat. Rev. Immunol. 2, 410-416.
27. Letterio, J. J. & Roberts, A. B. (1998) Annu. Rev. Immunol. 16, 137-161.
28. Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S. & Negrin, R. S. (2003) Nat. Med. 9, 1144-1150.
29. Marks, P. A., Rifkind, R. A., Richon, V. M. & Breslow, R. (2001) Clin. Cancer Res. 7, 759-760.
30. Kelly, W. K., Richon, V. M., O'Connor, O., Curley, T., MacGregor-Curtelli, B., Tong, W., Klang, M., Schwartz, L., Richardson, S., Rosa, E., et al. (2003) Clin. Cancer Res. 9, 3578-3588.